Similar articles

• Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.

  Boot JR, Brace G, Delatour CL, Dezutter N, Fairhurst J, Findlay J, Gallagher PT, Hoes I, Mahadevan S, Mitchell SN, Rathmell RE, Richards SJ, Simmonds RG, Wallace L, Whatton MA. Boot JR, et al. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5395-9. doi: 10.1016/j.bmcl.2004.08.005. Bioorg Med Chem Lett. 2004. PMID: 15454233
• Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.

  Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ. Vaishnavi SN, et al. Biol Psychiatry. 2004 Feb 1;55(3):320-2. doi: 10.1016/j.biopsych.2003.07.006. Biol Psychiatry. 2004. PMID: 14744476
• Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.

  Orjales A, Mosquera R, Toledo A, Pumar MC, García N, Cortizo L, Labeaga L, Innerárity A. Orjales A, et al. J Med Chem. 2003 Dec 4;46(25):5512-32. doi: 10.1021/jm0309349. J Med Chem. 2003. PMID: 14640559
• Beyond monoamine-based therapies: clues to new approaches.

  Skolnick P. Skolnick P. J Clin Psychiatry. 2002;63 Suppl 2:19-23. J Clin Psychiatry. 2002. PMID: 15453010 Review.
• Catecholamine reuptake and storage. Overview.

  Bönisch H, Eiden L. Bönisch H, et al. Adv Pharmacol. 1998;42:149-64. Adv Pharmacol. 1998. PMID: 9327868 Review. No abstract available.